Physician profile
Amy B Shepherd
NPI 1881638666
$3,696.54
in general payments reported to CMS, 2019-2025
19 companies · $502 in 2025
The $502 reported for 2025 was more than what 91% of Pediatric Emergency Medicine (Pediatrics) providers received nationally (typical 2025 total: $53.43).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $464 · 2021: $438 · 2022: $503 · 2023: $586 · 2024: $628 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,716.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $719.68 | 2019-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $629.09 | 2019-2024 | Jornay Pm |
| Corium, LLC | $425.05 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $339.23 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $309.38 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $256.14 | 2021-2024 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $205.09 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $176.81 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $132.66 | 2020-2021 | |
| Pfizer INC. | $124.72 | 2019-2025 | |
| Genentech USA, INC. | $115.21 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $89.43 | 2024-2025 | |
| Ars Pharmaceuticals Operations, INC. | $40.57 | 2025 | Neffy |
| Neos Therapeutics, Lp | $30.42 | 2019-2020 | |
| Shire North American Group INC | $28.26 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $25.80 | 2019 | |
| Abbott Laboratories | $20.98 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.03 | 2023 | Flumist Quadrivalent |
| Almirall LLC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.